4basebio PLC (AIM:4BB)
London · Delayed Price · Currency is GBP · Price in GBX 483.44
-1.56 (-0.32%)
May 6, 2026, 1:12 PM GMT
4basebio Market Cap
4basebio has a market cap or net worth of 75.07 million as of May 6, 2026. Its market cap has decreased by -47.89% in one year.
Market Cap
75.07M
Enterprise Value
64.39M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
483.44
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 41.57M to 75.07M, an increase of 80.57%. That is a compound annual growth rate of 12.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 75.07M | -21.14% |
| Dec 31, 2025 | 95.19M | -38.57% |
| Dec 31, 2024 | 154.94M | 84.96% |
| Dec 29, 2023 | 83.77M | -4.21% |
| Dec 30, 2022 | 87.45M | 15.45% |
| Dec 31, 2021 | 75.75M | 82.22% |
| Feb 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 156.70M |
| Bioventix | 90.13M |
| Faron Pharmaceuticals Oy | 82.80M |
| Ondine Biomedical | 61.05M |
| hVIVO | 50.15M |
| Hemogenyx Pharmaceuticals | 43.47M |
| Poolbeg Pharma | 30.32M |
| Sareum Holdings | 27.96M |